Hotel

FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections

SHANGHAI,Jan. 2,2025-- Shanghai MicuRx Pharmaceutical Co.,Ltd. ("MicuRx",688373.SH) announced that MRX-5,its self-developed anti-infection drug,has been granted Orphan Drug Designation (ODD

01-03

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

WUHAN,China,Jan. 3,2025-- Hanx Biopharmaceuticals,CO. Ltd,an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical need diseases,today

01-03

HZICC: BRLC launches initiatives for a global journey from Hangzhou

HANGZHOU,China,Jan. 2,2025-- Hangzhou,long renowned as a historic and cultural hub,is increasingly making strides in global cultural communication and trade with the help of the UCLG ASPAC on the Belt

01-03

CES 2025 Preview: TESSAN to Showcase Charging Solutions for Enhanced Connectivity and Convenience

LAS VEGAS,Dec. 25,2024-- The leading charging solution providerTESSAN has announced its participation in CES 2025,where it will present its latest innovations designed to enhance connectivity and conv

01-03

Treat Yourself to a New Christmas Experience by Self-Gifting viaim's AI Recording Earbuds, Perfect for a More Pleasant and Efficient Workplace

SINGAPORE,Dec. 26,2024-- As Christmas approaches,the concept of self-gifting has become more popular with top business executives to help them get into the holiday mood. Especially designed for the of

01-03

Haikou delivers mix of tradition and cutting-edge industry

BEIJING,Dec. 26,2024-- A news report from China Daily: Haikou,capital of South China’s Hainan province,is a vibrant metropolis known for its bustling ports,golden beaches and profound culture. Join M

01-03

iQIYI leads genre-specific storytelling with the return of its trend-setting 'Light On Theater,' featuring seven new suspense dramas

Five years on,the pioneering drama brand remains the benchmark for suspense BEIJING,Dec. 26,2024-- iQIYI,China\'s leading online entertainment platform,announced this month the return of its acclaime

01-03

iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

BEIJING,Dec. 26,2024-- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"),a leading provider of tech-powered,intellectual development products in China,today announced its unaudit

01-03

CLOU Electronics Earns Global Recognition in BloombergNEF's 2024 Bankability Rankings

DALLAS,Dec. 26,2024-- Bloomberg New Energy Finance (BNEF) has released its Storage Providers and Integrators Bankability List 2024,with CLOU Electronics achieving a notable improvement in its ranking

01-03

AUTOCRYPT to Showcase Award-Winning Cybersecurity Solutions at CES 2025

SEOUL,South Korea,Dec. 26,2024-- AUTOCRYPT,a global leader in automotive cybersecurity and testing solutions,has announced its participation in the 2025 Consumer Electronics Show (CES) in Las Vegas fr

01-03

Home Previous 56 57 58 59 60 61 62 Next Tail

10 Items Per Page (Page 59 / 99) Total 986 Items

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map